​

Vicarious Surgical Stock (NYSE:RBOT)

ForecastOwnershipFinancialsChartTranscripts
Vicarious Surgical by TradingView

Previous Close

$0.04

52W Range

$0.03 - $7.72

50D Avg

$0.09

200D Avg

$1.09

Market Cap

$265.57K

Avg Vol (3M)

$54.72K

Beta

1.86

Div Yield

-

RBOT Company Profile

Vicarious Surgical Inc. is dedicated to the development and commercialization of advanced single-incision surgical robotics. Their innovative technology is designed to give surgeons a virtual, immersive presence within the patient's body, facilitating highly precise and minimally invasive operations. The company's primary product, the Vicarious System, is a sophisticated single-incision robot engineered specifically for procedures like ventral hernia repair. Established in 2014, Vicarious Surgical Inc. operates from its corporate headquarters in Waltham, Massachusetts.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

US

Employees

48

IPO Date

Sep 04, 2020

Website

RBOT Performance

RBOT Financial Summary

Dec 25Dec 24Dec 23
Revenue---
Operating Income$-50.03M$-66.56M$-80.67M
Net Income$-50.18M$-63.22M$-71.07M
EBITDA$-50.03M$-61.12M$-69.19M
Basic EPS$-8.19$-10.72$-14.70
Diluted EPS$-8.19$-10.72$-14.60

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts

Q3 25Nov 12, 25 | 4:30 PM
Q2 25Aug 12, 25 | 4:30 PM
Q1 25May 12, 25 | 4:30 PM

Peer Comparison

TickerCompany
INTSIntensity Therapeutics, Inc.
QTTBQ32 Bio Inc.
NXLNexalin Technology, Inc.
PIIIP3 Health Partners Inc.
HYPDHyperion DeFi, Inc.
MODDModular Medical, Inc.
BOLDBoundless Bio, Inc.